Dr. O’Connell’s Professional Accomplishments
Publications and Presentations
- Nouri K, O’Connell C, Rivas M. “Imiquimod in the Treatment of Bowen’s Disease and Invasive Squamous Cell Carcinoma.” Journal of Drugs in Dermatology 2003: 2(6); 669-673.
- Nouri K, O’Connell C, Alonso A, Rivas M, Alonso Y. “The Miami Special: An Efficient Tool for Mounting Specimens in Mohs Surgery.” J Drugs in Dermatol March 2004; 3(2):175-177.
- O’Connell C, Wilentz S, Buchholz R . “Aquired Zinc Deficiency: Case Report and Review of Literature” presented at the Caribbean Dermatology Symposium January 2007.
- O’Connell C. “X-Linked Ichthyosis.” Accepted for live patient live patient viewing and presentation, American Academy of Dermatology summer meeting, 2007.
- O’Connell C. “Scleroderma”. Accepted for live patient viewing and presentation, American Academy of Dermatology summer meeting, 2007.
- O’ Connell C, Oranje A, Van Gysel D, Silverberg NB. “Congenital Molluscum Contagiosum: Report of Four Cases and Review of the Literature”. Pediatric Dermatology 2008; 25(5): 553-556.
- Brandt F, O’Connell C, Cazzaniga A, Waugh JM: Efficacy and Safety Evaluation of a Novel Botulinum Toxin Topical Gel for the Treatment of Moderate to Severe Lateral Canthal Lines. Dermatol Surg; 2010 Dec; 36 Suppl 4:2111-8.
- O’Connell C. American Academy of Dermatology. Filler Choices. Oral presentation. 2012. San Diego, CA.
Clinical Studies as Sub Investigator
A phase 3, multi center, long term, repeat-treatment, open label, single arm trial to demonstrate the safety of repeat treatment with PurTox for the treatment of glabellar rhytides (frown lines). 2009.
A phase 2, double-blind, randomized, parallel-group, controlled, dose-ranging, multi-center study to evaluate the safety and efficacy of rt001, a botulinum toxin type a topical gel, for the treatment of moderate to severe lateral canthal lines in adults. Feb 2009.
A post approval, multicenter, open-label, longitudinal, uncontrolled study of cosmetic tissue augmentation product (CTA) in the treatment of nasolabial folds in people of color. Feb 2009.
A phase 2, double-blind, randomized, parallel-group, controlled, repeat dose, single center study to evaluate the efficacy and safety of rt001, a botulinum toxin type a topical gel, for the treatment of moderate to severe lateral canthal lines in adults. Aug 2009.
A pivotal, USA, randomized, evaluator-blinded, active-controlled, multi-center, parallel group comparison study of lsir versus JUVÉDERM® Ultra in the treatment of moderate to severe facial folds and wrinkles. Nov 2009.
Post marketing study to evaluate alternative treatment regimens for improvement of wrinkles, skin tone and skin texture of the face. Nov 2009.
A randomized, evaluator-blinded, no-treatment-controlled study of the effectiveness and safety of Restylane® in the augmentation of soft tissue fullness of the lips. 2010.
An open label study of the safety of Restylane® and Perlane® in the correction of peri-oral wrinkles. 2010.
A phase 2, double-blind, randomized, parallel-group, controlled, repeat dose, single center study to evaluate the efficacy and safety of RT001, a botulinum toxin type a topical gel, for the treatment of moderate to severe lateral canthal lines in adults. 2010.
A phase 2, double blind, randomized, 4-arm, controlled, multicenter study to evaluate the efficacy and safety of a single dose of RT001 topical gel for the treatment of moderate to severe lateral canthal lines in adults. 2010.
A pivotal, USA, randomized, evaluator-blinded, active-controlled, multicenter, split face comparison study of Emervel Classic Lidocaine versus JUVÉDERM Ultra in the treatment of moderate to severe facial wrinkles and folds. 2010.
A controlled, randomized, double blind, within-subject, multi-center, prospective clinical trial (pivotal study) of Teosyal® PureSense Global Action vs JUVÉDERM® Ultra XC and Teosyal® PureSense Deep Lines and Ultra Deep vs JUVÉDERM® Ultra Plus XC in the treatment of severe to moderate facial wrinkles such as nasolabial folds. 2011.
A randomized, evaluator-blinded, no treatment controlled study of the effectiveness and safety of Perlane-L in the correction of mid-face volume deficit and/or mid-face contour deficiency. 2012.
A randomized, evaluator blinded, no treatment controlled study of the effectiveness and safety of small particle hyaluronic acid plus lidocaine (SPHAL) in the augmentation of soft tissue fullness of the lips. 2012.